DK1636206T3 - Imidazolderivater som glutamatreceptorantagonister - Google Patents
Imidazolderivater som glutamatreceptorantagonisterInfo
- Publication number
- DK1636206T3 DK1636206T3 DK04739484T DK04739484T DK1636206T3 DK 1636206 T3 DK1636206 T3 DK 1636206T3 DK 04739484 T DK04739484 T DK 04739484T DK 04739484 T DK04739484 T DK 04739484T DK 1636206 T3 DK1636206 T3 DK 1636206T3
- Authority
- DK
- Denmark
- Prior art keywords
- receptor antagonists
- glutamate receptor
- imidazole derivatives
- imidazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03012200 | 2003-06-05 | ||
| PCT/EP2004/005881 WO2004108701A1 (en) | 2003-06-05 | 2004-06-01 | Imidazole derivatives as glutmate receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1636206T3 true DK1636206T3 (da) | 2008-02-11 |
Family
ID=33483899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04739484T DK1636206T3 (da) | 2003-06-05 | 2004-06-01 | Imidazolderivater som glutamatreceptorantagonister |
Country Status (39)
| Country | Link |
|---|---|
| US (3) | US7332510B2 (da) |
| EP (1) | EP1636206B1 (da) |
| JP (1) | JP4401384B2 (da) |
| KR (1) | KR100778948B1 (da) |
| CN (1) | CN100408572C (da) |
| AR (1) | AR044478A1 (da) |
| AT (1) | ATE377008T1 (da) |
| AU (1) | AU2004245208B2 (da) |
| BR (1) | BRPI0411095B8 (da) |
| CA (1) | CA2527315C (da) |
| CL (1) | CL2004001347A1 (da) |
| CR (1) | CR8094A (da) |
| CY (1) | CY1107856T1 (da) |
| DE (1) | DE602004009796T2 (da) |
| DK (1) | DK1636206T3 (da) |
| EA (1) | EA010577B1 (da) |
| EC (1) | ECSP056202A (da) |
| ES (1) | ES2294504T3 (da) |
| GT (1) | GT200400117A (da) |
| HK (1) | HK1093070A1 (da) |
| HN (1) | HN2004000208A (da) |
| HR (1) | HRP20070529T3 (da) |
| IL (1) | IL171930A (da) |
| MA (1) | MA27881A1 (da) |
| MX (1) | MXPA05013149A (da) |
| MY (2) | MY137272A (da) |
| NO (1) | NO332143B1 (da) |
| NZ (1) | NZ543637A (da) |
| PA (1) | PA8604101A1 (da) |
| PE (1) | PE20050162A1 (da) |
| PL (1) | PL1636206T3 (da) |
| PT (1) | PT1636206E (da) |
| RS (1) | RS53183B (da) |
| SI (1) | SI1636206T1 (da) |
| TN (2) | TNSN05309A1 (da) |
| TW (1) | TWI338007B (da) |
| UA (1) | UA80888C2 (da) |
| WO (1) | WO2004108701A1 (da) |
| ZA (2) | ZA200509807B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7531529B2 (en) | 2003-06-05 | 2009-05-12 | Roche Palo Alto Llc | Imidazole derivatives |
| UA80888C2 (en) * | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
| US7452909B2 (en) | 2003-09-04 | 2008-11-18 | Hoffman-La Roche Inc. | Imidazole derivatives |
| JP4690395B2 (ja) | 2004-06-01 | 2011-06-01 | エフ．ホフマン−ラ ロシュ アーゲー | ｍＧｌｕ５レセプターアンタゴニストとしてのピリジン−４−エチニル−イミダゾール及びピラゾール |
| GB0514296D0 (en) * | 2005-07-12 | 2005-08-17 | Novartis Ag | Organic compounds |
| DE102006011574A1 (de) | 2006-03-10 | 2007-10-31 | Grünenthal GmbH | Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln |
| AU2007336369B2 (en) * | 2006-12-21 | 2013-01-17 | F. Hoffmann-La Roche Ag | Polymorphs of a mGluR5 receptor antagonist |
| US8334287B2 (en) * | 2009-07-17 | 2012-12-18 | Hoffmann-La Roche Inc. | Imidazoles |
| US20120040008A1 (en) * | 2010-08-11 | 2012-02-16 | Ashish Chatterji | Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
| US20120039999A1 (en) | 2010-08-11 | 2012-02-16 | Ashish Chatterji | Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
| KR20140018286A (ko) | 2011-03-18 | 2014-02-12 | 노파르티스 아게 | 파킨슨병에서의 도파민 유발 이상운동증에서 사용하기 위한 알파 7 니코틴성 아세틸콜린 수용체 활성화제 및 mGluR5 길항제의 조합물 |
| KR101684816B1 (ko) * | 2012-10-18 | 2016-12-20 | 에프. 호프만-라 로슈 아게 | mGluR5 수용체 활성의 조절제로서 에틴일 유도체 |
| NZ703537A (en) * | 2012-10-18 | 2018-06-29 | Hoffmann La Roche | Ethynyl derivatives |
| EA201891948A1 (ru) * | 2016-03-30 | 2019-04-30 | Синнтаксис Аб | Отрицательные аллостерические модуляторы метаботропного глутаматного рецептора 5 для применения в лечении зрелых повреждений головного мозга |
| WO2021245281A1 (en) | 2020-06-05 | 2021-12-09 | Noema Pharma Ag | Methods of treatment of tuberous sclerosis complex |
| WO2022023519A1 (en) * | 2020-07-30 | 2022-02-03 | Noema Pharma Ag | Methods of treatment of trigeminal neuralgia |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4508560A (en) * | 1981-11-11 | 1985-04-02 | Ciba Geigy Corporation | Certain pyridylacetylene compounds, compositions containing same and herbicidal methods of use |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| CA2383524C (en) | 1999-08-31 | 2010-09-28 | Merck & Co., Inc. | Thiazolyl alkynyl compounds and methods of use thereof |
| US7205297B2 (en) * | 2000-07-24 | 2007-04-17 | Krenitsky Pharmaceuticals, Inc. | Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| CN1257894C (zh) * | 2000-12-04 | 2006-05-31 | 弗·哈夫曼-拉罗切有限公司 | 作为谷氨酸受体拮抗剂的苯基乙烯基或苯基乙炔基衍生物 |
| CA2470612A1 (en) * | 2001-12-19 | 2003-07-03 | Merck & Co., Inc. | Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| CA2503245A1 (en) * | 2002-10-24 | 2004-05-06 | Merck & Co., Inc. | Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| TWI292318B (en) * | 2003-03-10 | 2008-01-11 | Hoffmann La Roche | Imidazol-4-yl-ethynyl-pyridine derivatives |
| UA80888C2 (en) * | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
| US7091222B2 (en) * | 2003-07-03 | 2006-08-15 | Hoffmann-La Roche Inc. | Imidazole derivatives |
-
2004
- 2004-01-06 UA UAA200512695A patent/UA80888C2/uk unknown
- 2004-06-01 PL PL04739484T patent/PL1636206T3/pl unknown
- 2004-06-01 CN CNB2004800156669A patent/CN100408572C/zh active Active
- 2004-06-01 DE DE602004009796T patent/DE602004009796T2/de active Active
- 2004-06-01 PT PT04739484T patent/PT1636206E/pt unknown
- 2004-06-01 EA EA200501887A patent/EA010577B1/ru not_active IP Right Cessation
- 2004-06-01 NZ NZ543637A patent/NZ543637A/en unknown
- 2004-06-01 MX MXPA05013149A patent/MXPA05013149A/es active IP Right Grant
- 2004-06-01 SI SI200430525T patent/SI1636206T1/sl unknown
- 2004-06-01 CA CA2527315A patent/CA2527315C/en active Active
- 2004-06-01 KR KR1020057023137A patent/KR100778948B1/ko active IP Right Grant
- 2004-06-01 BR BRPI0411095A patent/BRPI0411095B8/pt active IP Right Grant
- 2004-06-01 RS YU20050892A patent/RS53183B/en unknown
- 2004-06-01 WO PCT/EP2004/005881 patent/WO2004108701A1/en active IP Right Grant
- 2004-06-01 ES ES04739484T patent/ES2294504T3/es active Active
- 2004-06-01 AU AU2004245208A patent/AU2004245208B2/en active Active
- 2004-06-01 DK DK04739484T patent/DK1636206T3/da active
- 2004-06-01 AT AT04739484T patent/ATE377008T1/de active
- 2004-06-01 JP JP2006508238A patent/JP4401384B2/ja active Active
- 2004-06-01 EP EP04739484A patent/EP1636206B1/en active Active
- 2004-06-02 CL CL200401347A patent/CL2004001347A1/es unknown
- 2004-06-02 TW TW093115811A patent/TWI338007B/zh active
- 2004-06-02 PE PE2004000558A patent/PE20050162A1/es active IP Right Grant
- 2004-06-02 US US10/858,969 patent/US7332510B2/en active Active
- 2004-06-02 PA PA20048604101A patent/PA8604101A1/es unknown
- 2004-06-03 MY MYPI20042150A patent/MY137272A/en unknown
- 2004-06-03 GT GT200400117A patent/GT200400117A/es unknown
- 2004-06-03 HN HN2004000208A patent/HN2004000208A/es unknown
- 2004-06-03 AR ARP040101908A patent/AR044478A1/es active IP Right Grant
-
2005
- 2005-05-27 MY MYPI20052424A patent/MY143353A/en unknown
- 2005-11-13 IL IL171930A patent/IL171930A/en active IP Right Grant
- 2005-11-14 CR CR8094A patent/CR8094A/es unknown
- 2005-11-18 NO NO20055465A patent/NO332143B1/no unknown
- 2005-12-01 TN TNP2005000309A patent/TNSN05309A1/fr unknown
- 2005-12-02 ZA ZA200509807A patent/ZA200509807B/en unknown
- 2005-12-02 EC EC2005006202A patent/ECSP056202A/es unknown
- 2005-12-09 MA MA28648A patent/MA27881A1/fr unknown
-
2006
- 2006-11-21 ZA ZA200609681A patent/ZA200609681B/xx unknown
- 2006-11-27 TN TNP2006000391A patent/TNSN06391A1/fr unknown
- 2006-12-18 HK HK06113874A patent/HK1093070A1/xx unknown
-
2007
- 2007-10-31 US US11/930,258 patent/US8481548B2/en active Active
- 2007-11-20 HR HR20070529T patent/HRP20070529T3/xx unknown
- 2007-12-13 US US11/955,421 patent/US7973165B2/en active Active
-
2008
- 2008-01-11 CY CY20081100047T patent/CY1107856T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2017032I2 (el) | Παραγωγα (θειο)καρβαμοϋλ-κυκλοεξανιου ως ανταγωνιστες των υποδοχεων d3/d2 | |
| DK1761519T3 (da) | Indolderivater som histaminreceptorantagonister | |
| DK1833791T3 (da) | 2,3,4,9-tetrahydor-1H-carbazolderivater som CRTH2 receptorantagonister | |
| DK1501809T3 (da) | Trizolderivater som tachykininreceptorantagonister | |
| IL171930A0 (en) | Imidazole derivatives as glutamate receptor antagonists | |
| DK1904477T3 (da) | Indol-3-carbonyl-spiro-piperodom-derivater som V1A-receptorantagonister | |
| NO20054951D0 (no) | Prostaglandinanaloger som EP4-reseptorantagonister | |
| DK1562595T3 (da) | Diarylethere som opioidreceptorantagonister | |
| NO20052797D0 (no) | Fenyl eller heteroaryl aminoalkanderivater som IP-reseptorantagonister | |
| DK1499316T3 (da) | (1-4-piperidinyl)benzimidazolderivater anvendelige som histamin-H3-antagonister | |
| DK1539742T3 (da) | Indolderivater, der er nyttige som histamin H3-antagonister | |
| DK1309559T3 (da) | 4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister | |
| NO20051042L (no) | Pyrimidylsulfonamidderivater som kemokinreseptormodulatorer | |
| DK1802307T3 (da) | Pyrrolidinderivater som histamin-receptor-ligander | |
| DK1740569T3 (da) | Imidazol-derivater som TAFla-inhibitorer | |
| DK1928821T3 (da) | Carboxamidderivater som muscarinreceptorantagonister | |
| DK1305319T3 (da) | 4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister | |
| NO20055758D0 (no) | Heteroarylsubstituerte imidazolderivater som glutamatreseptorantagonister | |
| DK1912976T3 (da) | Indol-3-YL-carbonyl-piperidin-benzoimidazolderivater som V1A-receptorantagonister | |
| DK1648882T3 (da) | 3-fluor-piperidiner som NMDA/NR2B-antagonister | |
| NO20044373L (no) | Azetidinderivater som CCR-3-reseptorantagonister | |
| DE60316411D1 (de) | Thiazolderivate als npy-rezeptorantagonisten | |
| DK1560828T3 (da) | Imidazoquinolinderivater som adenosin-A3-receptorligander | |
| NO20055725D0 (no) | Glutamatreseptorantagonister som neurobeskyttende midler | |
| DK1558259T3 (da) | Ureaderivater som IL-8 -receptorantagonister |